Inhibikase Therapeutics Inc

NASDAQ:IKT   3:55:57 PM EDT
2.37
-0.07 (-2.87%)
Equity Financing / Related, Initial Public Offerings

Inhibikase Therapeutics Prices Follow-On Public Offering Of Common Stock

Published: 06/15/2021 23:50 GMT
Inhibikase Therapeutics Inc (IKT) - Inhibikase Therapeutics Prices Follow-on Public Offering of Common Stock.
Inhibikase Therapeutics - Pricing of Underwritten Public Offering of 15 Million Shares of Its Common Stock at a Public Offering Price of $3.00 per Share.